Weight ManagementJuly 25, 2026·4 min read
By the CIRRUS Editorial Team — how we write and source this
GLP-1 drugs and gastroparesis: separating a rare risk from routine nausea
Most GI side effects on semaglutide are dose-related and transient. A small number of cases are something else entirely.
GLP-1 drugs work partly by slowing gastric emptying — food stays in the stomach longer, which is a core mechanism behind appetite suppression, and it's also why nausea, bloating, and early fullness are the most commonly reported side effects, especially during dose escalation. For the large majority of patients, this resolves or becomes manageable as the body adjusts and as dosing follows the recommended slow titration schedule.
A distinct and much rarer concern is gastroparesis — a more severe, sometimes persistent form of delayed gastric emptying that can cause chronic vomiting, severe abdominal pain, and dehydration. Case reports and post-marketing surveillance have documented this in a small subset of GLP-1 users, and some cases have persisted after stopping the drug, which is different from ordinary transient nausea.
The distinguishing signal is severity and duration: routine nausea that fades within days of each dose increase is expected. Vomiting that's persistent, unrelated to a specific dose increase, or accompanied by severe pain warrants contacting the prescriber promptly rather than waiting it out.
This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.